Trial of intrathecal rituximab in progressive multiple sclerosis patients with evidence of leptomeningeal contrast enhancementPavan Bhargava, Ellen M. Mowry, Roy E. Strowd et al.|Multiple Sclerosis and Related Disorders|2019Cited by 70